Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 1;216(suppl_9):S801-S804.
doi: 10.1093/infdis/jix402.

The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action

Silvia Bertagnolio  1 , Rachel L Beanland  2 , Michael R Jordan  3 , Meg Doherty  1 , Gottfried Hirnschall  1
Affiliations

The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action

Silvia Bertagnolio et al. J Infect Dis. .

Abstract

The global community, including the World Health Organization (WHO), has committed to ending the AIDS epidemic and to ensuring that 90% of people living with human immunodeficiency virus (HIV) are diagnosed, 90% start treatment, and 90% achieve and maintain virological suppression. The emergence of HIV drug resistance (HIVDR) as antiretroviral treatment programs expand could preclude the 90-90-90 targets adopted by the United Nations General Assembly at the High-Level Meeting on Ending AIDS from being achieved. The Global Action Plan on HIVDR is a call for collective action grounded on normative guidance providing a standardized and robust approach to monitoring, preventing, and responding to HIVDR over the next 5 years (2017-2021). WHO is committed to supporting country, global, regional, and national partners to implement and monitor the progress of the Global Action Plan. This article outlines the key components of WHO's strategy to tackle HIVDR and the role the organization takes in leading the global response to HIVDR.

Keywords: drug resistance; human immunodeficiency virus (HIV); monitoring; prevention; response.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Five strategic objectives of the Global Action Plan (GAP) on HIV Drug Resistance (2017–2021). Abbreviation: HIVDR, human immunodeficiency virus drug resistance.
See this image and copyright information in PMC

References

    1. United Nations General Assembly. Political Declaration on HIV and AIDS: On the Fast Track to Accelerate the Fight Against HIV and to End the AIDS Epidemic by 2030. Geneva Switzerland: UNAIDS; 2016.
    1. Phillips AN, Stover J, Cambiano V et al. Impact of HIV drug resistance on HIV/AIDS–Associated mortality, new infections, and antiretroviral therapy program costs in sub-Saharan Africa. J Infect Dis 2017; 215:1362–5. - PMC - PubMed
    1. UNAIDS. How AIDS changed everything—MDG6: 15 years, 15 lessons of hope from the AIDS responsehttps://issuu.com/unaids/docs/mdg6report_no-annexes_en?reader3=1.
    1. UNAIDS, WHO. Global AIDS Monitoring. Geneva, Switzerland: UNAIDS, 2017.
    1. Ávila-Ríos S, García-Morales C, Matías-Florentino M et al. Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey. Lancet HIV 2016; 3:e579–91. - PubMed

Publication types

MeSH terms

Substances